Cargando…
Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice
OBJECTIVE: To investigate the abundance and the prevalence of Dysosmobacter welbionis J115(T), a novel butyrate-producing bacterium isolated from the human gut both in the general population and in subjects with metabolic syndrome. To study the impact of this bacterium on host metabolism using diet-...
Autores principales: | Le Roy, Tiphaine, Moens de Hase, Emilie, Van Hul, Matthias, Paquot, Adrien, Pelicaen, Rudy, Régnier, Marion, Depommier, Clara, Druart, Céline, Everard, Amandine, Maiter, Dominique, Delzenne, Nathalie M, Bindels, Laure B, de Barsy, Marie, Loumaye, Audrey, Hermans, Michel P, Thissen, Jean-Paul, Vieira-Silva, Sara, Falony, Gwen, Raes, Jeroen, Muccioli, Giulio G, Cani, Patrice D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862106/ https://www.ncbi.nlm.nih.gov/pubmed/34108237 http://dx.doi.org/10.1136/gutjnl-2020-323778 |
Ejemplares similares
-
Dysosmobacter welbionis effects on glucose, lipid, and energy metabolism are associated with specific bioactive lipids
por: Moens de Hase, Emilie, et al.
Publicado: (2023) -
Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients
por: Rodriguez, Julie, et al.
Publicado: (2020) -
Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism
por: Duparc, Thibaut, et al.
Publicado: (2017) -
Identification of new enterosynes using prebiotics: roles of bioactive lipids and mu-opioid receptor signalling in humans and mice
por: Abot, Anne, et al.
Publicado: (2021) -
Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates
por: Vandeputte, Doris, et al.
Publicado: (2016)